Growth opportunities center on expanded genetic panels, telehealth-enabled regional access, lab automation, awareness campaigns and integration with hospital prenatal care.Dublin, Oct. 07, 2026 (GLOBE ...

Mexico’s NIPT market is driven by preventive care, private healthcare expansion, advanced sequencing, safer screening and improving diagnostic access.Dublin, Oct. 07, 2026 (GLOBE NEWSWIRE) -- "Mexico ...

While noninvasive prenatal testing (NIPT) has revolutionized prenatal diagnostics by allowing the detection of a number of genetic problems in a fetus, it is currently limited and thus misses many ...

Emory Genetics Laboratory, through a partnership with Verinata Health, an Illumina company, will begin providing the verifi® prenatal test for patients desiring non-invasive prenatal testing. All ...

Natera has introduced a non-invasive prenatal test (NIPT), Fetal Focus, specifically designed for inherited conditions. According to the company, when a pregnant individual is found to carry a ...

is valued at an estimated USD 7.2 billion in 2024 and is projected to reach USD 14.1 billion by 2029 at a CAGR of 14.5% during the forecast period. The global non-invasive prenatal testing (NIPT) ...

Forbes contributors publish independent expert analyses and insights. William A. Haseltine, Ph.D., covers genomics and regenerative medicine Non-invasive prenatal testing, or NIPT, now shapes critical ...

While non-invasive prenatal testing (NIPT) has revolutionized prenatal diagnostics by allowing the detection of a number of genetic problems in a fetus, it is currently limited and thus misses many ...

Indentifai Genetics, an Israeli company seeking to commercialise an AI-powered prenatal test, has successfully listed on ...

Understanding how fetal DNA travels in a pregnant woman’s blood could unlock the next generation of prenatal screening, ...